LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study.

    Liu, Jian / Dong, Yong-Quan / Yin, Jie / He, Guojun / Wu, Xiaoxin / Li, Jianping / Qiu, Yunqing / He, Xuelin

    Medicine

    2020  Volume 99, Issue 26, Page(s) e21012

    Abstract: ... to characterize a group of critically ill patients in a single-center study.This was a retrospective case series ... 13 days), to artificial liver plasma exchange was 12 days (IQR 9.75-14.75 days), and ... received MV. Six required ECMO. Nine received artificial liver plasma exchange. Mortality was 0 at day 28 ...

    Abstract COVID-19 is an emerging infectious disease capable of causing severe pneumonia. We aimed to characterize a group of critically ill patients in a single-center study.This was a retrospective case series of 23 patients with confirmed COVID-19-related critical illness in the intensive care unit (ICU) of a hospital in Hangzhou Zhejiang Province between January 22 and March 20, 2020.Of the 23 critically ill patients, the median age was 66 years (interquartile range [IQR] 59-80 years). The median time from disease onset to ICU admission was 10 days (IQR 6-11 days), to mechanical ventilation (MV) was 11 days (IQR 7.75-13 days), to artificial liver plasma exchange was 12 days (IQR 9.75-14.75 days), and to extracorporeal membrane oxygenation (ECMO) was 22 days (IQR 17.5-30 days). Nine patients required high flow oxygen. Fourteen patients received MV. Six required ECMO. Nine received artificial liver plasma exchange. Mortality was 0 at day 28.Mortality was 0 at day 28 in our single-center study. Extracorporeal membrane oxygenation reduced the requirements for ventilator support. Artificial liver plasma exchange significantly reduced inflammatory cytokine levels. These supportive therapies helped to extend the patients' survival times and increase the chance of follow-up treatments.
    MeSH term(s) Aged ; Aged, 80 and over ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/therapy ; Critical Illness ; Extracorporeal Membrane Oxygenation ; Female ; Humans ; Liver, Artificial ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/therapy ; Retrospective Studies
    Keywords covid19
    Language English
    Publishing date 2020-06-16
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000021012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange ; A retrospective study

    Liu, Jian / Dong, Yong-Quan / Yin, Jie / He, Guojun / Wu, Xiaoxin / Li, Jianping / Qiu, Yunqing / He, Xuelin

    Medicine

    2020  Volume 99, Issue 26, Page(s) e21012

    Keywords General Medicine ; covid19
    Language English
    Publisher Ovid Technologies (Wolters Kluwer Health)
    Publishing country us
    Document type Article ; Online
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/md.0000000000021012
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study

    Liu, Jian / Dong, Yong-Quan / Yin, Jie / He, Guojun / Wu, Xiaoxin / Li, Jianping / Qiu, Yunqing / He, Xuelin

    Medicine (Baltimore)

    Abstract: ... to characterize a group of critically ill patients in a single-center study.This was a retrospective case series ... 13 days), to artificial liver plasma exchange was 12 days (IQR 9.75-14.75 days), and ... received MV. Six required ECMO. Nine received artificial liver plasma exchange. Mortality was 0 at day 28 ...

    Abstract COVID-19 is an emerging infectious disease capable of causing severe pneumonia. We aimed to characterize a group of critically ill patients in a single-center study.This was a retrospective case series of 23 patients with confirmed COVID-19-related critical illness in the intensive care unit (ICU) of a hospital in Hangzhou Zhejiang Province between January 22 and March 20, 2020.Of the 23 critically ill patients, the median age was 66 years (interquartile range [IQR] 59-80 years). The median time from disease onset to ICU admission was 10 days (IQR 6-11 days), to mechanical ventilation (MV) was 11 days (IQR 7.75-13 days), to artificial liver plasma exchange was 12 days (IQR 9.75-14.75 days), and to extracorporeal membrane oxygenation (ECMO) was 22 days (IQR 17.5-30 days). Nine patients required high flow oxygen. Fourteen patients received MV. Six required ECMO. Nine received artificial liver plasma exchange. Mortality was 0 at day 28.Mortality was 0 at day 28 in our single-center study. Extracorporeal membrane oxygenation reduced the requirements for ventilator support. Artificial liver plasma exchange significantly reduced inflammatory cytokine levels. These supportive therapies helped to extend the patients' survival times and increase the chance of follow-up treatments.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32590819
    Database COVID19

    Kategorien

To top